vs
CRYO CELL INTERNATIONAL INC（CCEL）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是CRYO CELL INTERNATIONAL INC的1.8倍（$14.0M vs $7.8M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -48.7%，领先58.5%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -2.3%），CRYO CELL INTERNATIONAL INC自由现金流更多（$1.2M vs $-736.0K），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs -0.1%）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
CCEL vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.8倍
$7.8M
营收增速更快
RVSB
高出12.6%
-2.3%
净利率更高
RVSB
高出58.5%
-48.7%
自由现金流更多
CCEL
多$1.9M
$-736.0K
两年增速更快
RVSB
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $14.0M |
| 净利润 | $-3.8M | $1.4M |
| 毛利率 | 77.9% | — |
| 营业利润率 | -50.6% | 12.4% |
| 净利率 | -48.7% | 9.8% |
| 营收同比 | -2.3% | 10.4% |
| 净利润同比 | -105.1% | 11.8% |
| 每股收益（稀释后） | $-0.46 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELRVSB
| Q4 25 | $7.8M | $14.0M | ||
| Q3 25 | $7.8M | $13.6M | ||
| Q2 25 | $7.9M | $13.3M | ||
| Q1 25 | $8.0M | $12.9M | ||
| Q4 24 | $8.0M | $12.7M | ||
| Q3 24 | $8.1M | $12.8M | ||
| Q2 24 | $8.0M | $12.2M | ||
| Q1 24 | $7.9M | $9.0M |
净利润CCELRVSB
| Q4 25 | $-3.8M | $1.4M | ||
| Q3 25 | $749.4K | $1.1M | ||
| Q2 25 | $355.8K | $1.2M | ||
| Q1 25 | $282.9K | $1.1M | ||
| Q4 24 | $-1.9M | $1.2M | ||
| Q3 24 | $1.1M | $1.6M | ||
| Q2 24 | $655.8K | $966.0K | ||
| Q1 24 | $556.2K | $-3.0M |
毛利率CCELRVSB
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
营业利润率CCELRVSB
| Q4 25 | -50.6% | 12.4% | ||
| Q3 25 | 24.3% | 10.2% | ||
| Q2 25 | 18.8% | 11.7% | ||
| Q1 25 | 13.3% | 11.3% | ||
| Q4 24 | -1.5% | 12.4% | ||
| Q3 24 | 17.2% | 15.5% | ||
| Q2 24 | 17.3% | 10.0% | ||
| Q1 24 | 10.5% | -47.5% |
净利率CCELRVSB
| Q4 25 | -48.7% | 9.8% | ||
| Q3 25 | 9.6% | 8.1% | ||
| Q2 25 | 4.5% | 9.2% | ||
| Q1 25 | 3.5% | 8.9% | ||
| Q4 24 | -23.2% | 9.7% | ||
| Q3 24 | 13.0% | 12.2% | ||
| Q2 24 | 8.2% | 7.9% | ||
| Q1 24 | 7.1% | -34.7% |
每股收益（稀释后）CCELRVSB
| Q4 25 | $-0.46 | $0.07 | ||
| Q3 25 | $0.09 | $0.05 | ||
| Q2 25 | $0.04 | $0.06 | ||
| Q1 25 | $0.03 | $0.05 | ||
| Q4 24 | $-0.23 | $0.06 | ||
| Q3 24 | $0.13 | $0.07 | ||
| Q2 24 | $0.08 | $0.05 | ||
| Q1 24 | $0.07 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $28.6M |
| 总债务越低越好 | $8.4M | — |
| 股东权益账面价值 | $-18.6M | $164.2M |
| 总资产 | $61.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCELRVSB
| Q4 25 | $3.3M | $28.6M | ||
| Q3 25 | $3.2M | $32.8M | ||
| Q2 25 | $4.4M | $34.2M | ||
| Q1 25 | $3.5M | $29.4M | ||
| Q4 24 | $3.5M | $25.3M | ||
| Q3 24 | $2.1M | $31.0M | ||
| Q2 24 | $1.5M | $27.8M | ||
| Q1 24 | $979.6K | $23.6M |
总债务CCELRVSB
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
股东权益CCELRVSB
| Q4 25 | $-18.6M | $164.2M | ||
| Q3 25 | $-14.8M | $163.5M | ||
| Q2 25 | $-15.6M | $162.0M | ||
| Q1 25 | $-14.7M | $160.0M | ||
| Q4 24 | $-13.2M | $158.3M | ||
| Q3 24 | $-9.6M | $160.8M | ||
| Q2 24 | $-10.7M | $155.9M | ||
| Q1 24 | $-10.3M | $155.6M |
总资产CCELRVSB
| Q4 25 | $61.7M | $1.5B | ||
| Q3 25 | $63.2M | $1.5B | ||
| Q2 25 | $64.4M | $1.5B | ||
| Q1 25 | $64.4M | $1.5B | ||
| Q4 24 | $64.7M | $1.5B | ||
| Q3 24 | $62.9M | $1.5B | ||
| Q2 24 | $62.6M | $1.5B | ||
| Q1 24 | $61.7M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $-736.0K |
| 自由现金流率自由现金流/营收 | 15.5% | -5.2% |
| 资本支出强度资本支出/营收 | 0.9% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $5.2M | $20.4M |
8季度趋势，按日历期对齐
经营现金流CCELRVSB
| Q4 25 | $1.3M | $-506.0K | ||
| Q3 25 | $2.5M | $16.8M | ||
| Q2 25 | $707.0K | $-697.0K | ||
| Q1 25 | $954.1K | $8.3M | ||
| Q4 24 | $2.2M | $2.2M | ||
| Q3 24 | $2.4M | $764.0K | ||
| Q2 24 | $1.8M | $5.4M | ||
| Q1 24 | $-356.9K | $12.8M |
自由现金流CCELRVSB
| Q4 25 | $1.2M | $-736.0K | ||
| Q3 25 | $2.5M | $16.4M | ||
| Q2 25 | $644.6K | $-773.0K | ||
| Q1 25 | $892.0K | $5.6M | ||
| Q4 24 | $2.1M | $1.9M | ||
| Q3 24 | $2.3M | $-1.4M | ||
| Q2 24 | $21.5K | $5.3M | ||
| Q1 24 | $-814.6K | $7.1M |
自由现金流率CCELRVSB
| Q4 25 | 15.5% | -5.2% | ||
| Q3 25 | 31.9% | 120.1% | ||
| Q2 25 | 8.1% | -5.8% | ||
| Q1 25 | 11.2% | 43.1% | ||
| Q4 24 | 26.8% | 15.0% | ||
| Q3 24 | 27.9% | -11.3% | ||
| Q2 24 | 0.3% | 43.7% | ||
| Q1 24 | -10.4% | 79.0% |
资本支出强度CCELRVSB
| Q4 25 | 0.9% | 1.6% | ||
| Q3 25 | 0.5% | 2.9% | ||
| Q2 25 | 0.8% | 0.6% | ||
| Q1 25 | 0.8% | 21.0% | ||
| Q4 24 | 0.1% | 2.4% | ||
| Q3 24 | 2.3% | 17.3% | ||
| Q2 24 | 21.8% | 0.9% | ||
| Q1 24 | 5.8% | 62.0% |
现金转化率CCELRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | 3.38× | 15.25× | ||
| Q2 25 | 1.99× | -0.57× | ||
| Q1 25 | 3.37× | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | 2.32× | 0.49× | ||
| Q2 24 | 2.70× | 5.63× | ||
| Q1 24 | -0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
